OLD National Bancorp IN Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OLD National Bancorp IN boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,295 shares of the medical equipment provider's stock after purchasing an additional 845 shares during the period. OLD National Bancorp IN's holdings in Intuitive Surgical were worth $2,622,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in Intuitive Surgical during the 4th quarter valued at $2,401,493,000. GAMMA Investing LLC boosted its holdings in shares of Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Capital Research Global Investors boosted its holdings in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $313,769,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Robert W. Baird reduced their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Truist Financial reduced their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 25,443 shares of company stock worth $12,692,195 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $557.08 on Monday. Intuitive Surgical, Inc. has a one year low of $413.52 and a one year high of $616.00. The business's 50-day simple moving average is $521.99 and its 200 day simple moving average is $539.16. The stock has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.